G Weirich1, P Schneider, C Fellbaum
1Institute of Pathology, Technical University of Munich, School of Medicine, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Identifying p53 alterations in thymic epithelial tumours using immunohistochemistry offers a new prognostic factor. This molecular marker aids in predicting tumour behavior beyond traditional histopathology, improving patient outcome evaluation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: